Search

everythinglearnresearchcommunity

for

Search:↓

Activating Nrf2 protects human hair follicles from oxidative stress and helps prevent hair growth inhibition.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Noncoding dsRNA boosts hair growth by activating TLR3 and increasing retinoic acid.

Nude mice with grafted human skin developed scars similar to human hypertrophic scars.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Cell aging can be both good and bad for tissue repair.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Regulatory T cells are essential for normal and improved wound healing in mice.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Caspases affect many cell functions and could help treat various diseases.

Certain gene variations increase the risk of alopecia areata in Koreans.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

The cornified envelope is crucial for skin's barrier function and involves key proteins and genetic factors.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.